EXINI Diagnostics AB | Software for quantitative analysis of PSMA PET/CT providing standardized, accurate, and rapid total-body quantitative output for PSMA PET/CT

Brief Product Description
Software for quantitative analysis of PSMA PET/CT providing standardized, accurate, and rapid total-body quantitative output for PSMA PET/CT
Technology
Full body prostate cancer disease quantification through PSMA PET/CT imaging.
This software quantitative analysis and standardized reporting of PSMA PET/CT image assessments. It uses Deep Learning technology on PSMA images to enhance:
Efficiency: Reduce the laborious task of defining and locating the disease
Consistency: Enhance the reproducibility and reliability among the readers
Accuracy: Maintain the high diagnostic accuracy
Standardization: Enable rapid detection and volumetric quantification of disease burden in PSMA images
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.